NYSE:SYK

Stryker - SYK Stock Forecast, Price & News

$223.26

+0.14 (+0.06%)

(As of 08/15/2022 11:28 AM ET)

Add

Compare

Today's Range: $222.04
▼
$224.51
50-Day Range: $189.27
▼
$230.70
52-Week Range: $188.84
▼
$281.16

Volume: 10,030 shs
Average Volume: 1.51 million shs
Market Capitalization: $84.43 billion

P/E Ratio: 41.12
Dividend Yield: 1.25%
Price Target: $256.00

Stryker MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 14.9% Upside
$256.00 Price Target
Short Interest: Healthy
1.44% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -0.95
Upright™ Environmental Score
News Sentiment: 0.12
Based on 10 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 9.70%
From $9.38 to $10.29 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.19 out of 5 stars

Medical Sector

9th out of 1,128 stocks

Surgical & Medical Instruments Industry

2nd out of 113 stocks

3.3

Analyst's Opinion

Consensus Rating
Stryker has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 10 buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $256.00, Stryker has a forecasted upside of 14.9% from its current price of $222.88.
Amount of Analyst Coverage
Stryker has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.0

Short Interest

Percentage of Shares Shorted
1.44% of the float of Stryker has been sold short.
Short Interest Ratio / Days to Cover
Stryker has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Stryker has recently decreased by 1.17%, indicating that investor sentiment is improving.

4.2

Dividend Strength

Dividend Yield
Stryker pays a meaningful dividend of 1.25%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Stryker has been increasing its dividend for 29 years.
Dividend Coverage
The dividend payout ratio of Stryker is 51.20%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Stryker will have a dividend payout ratio of 27.02% next year. This indicates that Stryker will be able to sustain or increase its dividend.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Stryker has received a 60.46% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Protective clothing", "Synthetic bone grafts", "Surgery simulation software", "Medical laboratory equipment", and "Bone cement" products. See details.
Environmental Sustainability
The Environmental Impact score for Stryker is -0.95.

2.8

News and Social Media Coverage

News Sentiment
Stryker has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Stryker this week, compared to 6 articles on an average week.
Search Interest
22 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 83% compared to the previous 30 days.
MarketBeat Follows
17 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 143% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Stryker insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.50% of the stock of Stryker is held by insiders.
Percentage Held by Institutions
74.52% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Stryker are expected to grow by 9.70% in the coming year, from $9.38 to $10.29 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Stryker is 41.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.73.
Price to Earnings Ratio vs. Sector
The P/E ratio of Stryker is 41.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 78.49.
Price to Earnings Growth Ratio
Stryker has a PEG Ratio of 2.71. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Stryker has a P/B Ratio of 5.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Stryker (NYSE:SYK) Stock

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on SYK shares. Piper Sandler lowered their price objective on shares of Stryker from $290.00 to $250.00 and set an "overweight" rating for the company in a research report on Wednesday, July 27th. StockNews.com lowered shares of Stryker from a "buy" rating to a "hold" rating in a report on Monday, May 2nd. Bank of America lowered shares of Stryker from a "buy" rating to a "neutral" rating in a report on Monday, July 11th. Edward Jones upgraded shares of Stryker from a "hold" rating to a "buy" rating in a report on Thursday, July 28th. Finally, Citigroup reduced their price target on shares of Stryker from $310.00 to $280.00 in a report on Tuesday, May 17th. Six investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $256.00.

Stryker Stock Up 0.1 %

Shares of NYSE:SYK traded up $0.22 during trading hours on Monday, hitting $223.34. 5,439 shares of the stock were exchanged, compared to its average volume of 1,506,748. The company has a quick ratio of 1.15, a current ratio of 2.00 and a debt-to-equity ratio of 0.85. Stryker has a 12 month low of $188.84 and a 12 month high of $281.16. The company has a market cap of $84.46 billion, a PE ratio of 41.09, a PEG ratio of 2.71 and a beta of 1.03. The firm has a fifty day moving average price of $206.00 and a 200-day moving average price of $235.85.

Stryker (NYSE:SYK - Get Rating) last issued its quarterly earnings results on Tuesday, July 26th. The medical technology company reported $2.25 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.28 by ($0.03). Stryker had a net margin of 11.79% and a return on equity of 23.34%. During the same quarter last year, the business posted $2.25 EPS. On average, sell-side analysts expect that Stryker will post 9.38 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, October 31st. Shareholders of record on Friday, September 30th will be paid a dividend of $0.695 per share. The ex-dividend date of this dividend is Thursday, September 29th. This represents a $2.78 dividend on an annualized basis and a yield of 1.24%. Stryker's payout ratio is 51.20%.

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Stock News Headlines

August 15, 2022 | businesswire.com

Global Large Joint Devices Market Report Suite 2022-2028 - ResearchAndMarkets.com - Business Wire

August 10, 2022 | americanbankingnews.com

Financial Survey: Stryker (NYSE:SYK) and Venus Concept (NASDAQ:VERO)

August 10, 2022 | americanbankingnews.com

Stryker Co. (NYSE:SYK) Receives $256.00 Average PT from Analysts

August 3, 2022 | benzinga.com

Stryker declares a $0.695 per share quarterly dividend - Benzinga

August 3, 2022 | marketwatch.com

Stryker Corp. stock falls Tuesday, still outperforms market - MarketWatch

August 1, 2022 | americanbankingnews.com

Stryker (NYSE:SYK) Raised to Buy at Edward Jones

July 31, 2022 | americanbankingnews.com

Oppenheimer Weighs in on Stryker Co.'s Q4 2022 Earnings (NYSE:SYK)

July 29, 2022 | americanbankingnews.com

Robert W. Baird Lowers Stryker (NYSE:SYK) Price Target to $240.00

July 29, 2022 | americanbankingnews.com

Stryker Co. (NYSE:SYK) Forecasted to Earn Q3 2022 Earnings of $2.21 Per Share

July 28, 2022 | finance.yahoo.com

Outlook on the Minimally Invasive Surgical Systems Global Market to 2030 - Featuring Medtronic, Intuitive Surgical and Stryker Among Others - Yahoo Finance

July 28, 2022 | finance.yahoo.com

Stryker's (NYSE:SYK) 9.1% CAGR outpaced the company's earnings growth over the same five-year period

July 28, 2022 | americanbankingnews.com

Truist Financial Increases Stryker (NYSE:SYK) Price Target to $220.00

July 28, 2022 | americanbankingnews.com

Wells Fargo & Company Cuts Stryker (NYSE:SYK) Price Target to $237.00

July 28, 2022 | americanbankingnews.com

Stryker (NYSE:SYK) Price Target Cut to $255.00 by Analysts at Royal Bank of Canada

July 28, 2022 | americanbankingnews.com

Stryker (NYSE:SYK) Price Target Lowered to $250.00 at Piper Sandler

July 28, 2022 | nasdaq.com

Stryker Corp. Q2 Profit Increases, but misses estimates

July 27, 2022 | finance.yahoo.com

Stryker's Q2 Earnings Miss Street View On Forex & Inflation Pressure

July 27, 2022 | finance.yahoo.com

Stryker's (SYK) Q2 Earnings and Revenues Miss Estimates

July 26, 2022 | seekingalpha.com

Stryker Corporation (SYK) CEO Kevin Lobo on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

July 26, 2022 | finance.yahoo.com

Stryker reports second quarter 2022 operating results - Yahoo Finance

July 26, 2022 | finance.yahoo.com

Stryker (SYK) Lags Q2 Earnings and Revenue Estimates

July 26, 2022 | seekingalpha.com

Stryker 2022 EPS estimate below consensus as supply chain challenges, inflation weigh - Seeking Alpha

July 26, 2022 | investors.com

Stryker Stock: CEO Is Confident In Sales Despite Dollar Squeeze On Profits | Investor's Business Daily - Investor's Business Daily

July 26, 2022 | finance.yahoo.com

Stryker reports second quarter 2022 operating results

July 26, 2022 | americanbankingnews.com

Stryker (NYSE:SYK) PT Lowered to $233.00 at Cowen

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Company Calendar

Ex-Dividend for 7/29 Dividend: 6/29/2022
Last Earnings: 7/26/2022
Dividend Payable: 7/29/2022
Today: 8/15/2022
Next Earnings (Estimated): 10/27/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:SYK
CUSIP: 86366710
CIK: 310764
Web: www.strykercorp.com
Phone: (269) 385-2600
Fax: 269-385-1062
Employees: 46,000
Year Founded: 1941

Price Target and Rating

Average Stock Price Forecast: $256.00
High Stock Price Forecast: $305.00
Low Stock Price Forecast: $205.00
Forecasted Upside/Downside: +14.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 15 Analysts

Profitability

EPS (Most Recent Fiscal Year): $5.43
Trailing P/E Ratio: 41.12
Forward P/E Ratio: 23.80
P/E Growth: 2.71
Net Income: $1.99 billion
Net Margins: 11.79%
Pretax Margin: 13.38%
Return on Equity: 23.34%
Return on Assets: 9.90%

Debt

Debt-to-Equity Ratio: 0.85
Current Ratio: 2.00
Quick Ratio: 1.15

Sales & Book Value

Annual Sales: $17.11 billion
Price / Sales: 4.93
Cash Flow: $11.84 per share
Price / Cash Flow: 18.86
Book Value: $39.42 per share
Price / Book: 5.66

Miscellaneous

Outstanding Shares: 378,154,000
Free Float: 353,574,000
Market Cap: $84.43 billion
Optionable: Optionable
Beta: 1.03

Social Links

Key Executives

Mr. Kevin A. Lobo (Age 57)
Chairman, CEO & Pres
Comp: $3.59M
Mr. Glenn S. Boehnlein (Age 60)
VP & CFO
Comp: $1.46M
Mr. Timothy John Scannell (Age 57)
Exec. Advisor
Comp: $1.74M
Mr. Viju S. Menon (Age 54)
Group Pres of Global Quality & Operations
Comp: $1.08M
Mr. J. Andrew Pierce (Age 48)
Group Pres of MedSurg & Neurotechnology
Comp: $1.41M
Mr. Spencer S. Stiles (Age 45)
Group Pres of Orthopaedics & Spine
Comp: $1.33M
Mr. William E. Berry Jr. (Age 56)
VP & Chief Accounting Officer
Mr. Robert C. Cohen
CTO and VP of Global R&D - Joint Replacement
Mr. Alan Douville
VP, Chief Information Officer & Chief Information Security Officer
Mr. Jason Beach
VP of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SYK Stock - Frequently Asked Questions

Should I buy or sell Stryker stock right now?: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 5 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SYK shares.
View SYK analyst ratings or view top-rated stocks.
What is Stryker's stock price forecast for 2022?: 15 brokerages have issued twelve-month price targets for Stryker's shares. Their SYK share price forecasts range from $205.00 to $305.00. On average, they anticipate the company's stock price to reach $256.00 in the next twelve months. This suggests a possible upside of 14.7% from the stock's current price.
View analysts price targets for SYK or view top-rated stocks among Wall Street analysts.
How have SYK shares performed in 2022?: Stryker's stock was trading at $267.42 at the beginning of 2022. Since then, SYK stock has decreased by 16.6% and is now trading at $223.12.
View the best growth stocks for 2022 here.
When is Stryker's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our SYK earnings forecast.
How were Stryker's earnings last quarter?: Stryker Co. (NYSE:SYK) announced its quarterly earnings data on Tuesday, July, 26th. The medical technology company reported $2.25 EPS for the quarter, missing analysts' consensus estimates of $2.28 by $0.03. Stryker had a net margin of 11.79% and a trailing twelve-month return on equity of 23.34%. During the same quarter last year, the firm posted $2.25 earnings per share.
Read the conference call transcript.
How often does Stryker pay dividends? What is the dividend yield for Stryker?: Stryker announced a quarterly dividend on Wednesday, August 3rd. Investors of record on Friday, September 30th will be given a dividend of $0.695 per share on Monday, October 31st. This represents a $2.78 annualized dividend and a dividend yield of 1.25%. The ex-dividend date of this dividend is Thursday, September 29th.
Read our dividend analysis for SYK.
Is Stryker a good dividend stock?: Stryker (NYSE:SYK) pays an annual dividend of $2.78 per share and currently has a dividend yield of 1.25%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 51.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 27.02% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.
What guidance has Stryker issued on next quarter's earnings?: Stryker updated its FY 2022 earnings guidance on Tuesday, August, 2nd. The company provided earnings per share guidance of $9.30-$9.50 for the period, compared to the consensus earnings per share estimate of $9.63. The company issued revenue guidance of -.

What is Kevin A. Lobo's approval rating as Stryker's CEO?: 1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Stryker own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).
What is Stryker's stock symbol?: Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."
Who are Stryker's major shareholders?: Stryker's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Greenleaf Trust (5.26%), Franklin Resources Inc. (1.37%), Northern Trust Corp (0.93%), Massachusetts Financial Services Co. MA (0.90%), Ontario Teachers Pension Plan Board (0.68%) and Mackenzie Financial Corp (0.61%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar, Timothy J Scannell and Timothy J Scannell.
View institutional ownership trends.
How do I buy shares of Stryker?: Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Stryker's stock price today?: One share of SYK stock can currently be purchased for approximately $223.12.
How much money does Stryker make?: Stryker (NYSE:SYK) has a market capitalization of $84.37 billion and generates $17.11 billion in revenue each year. The medical technology company earns $1.99 billion in net income (profit) each year or $5.43 on an earnings per share basis.
How many employees does Stryker have?: The company employs 46,000 workers across the globe.
Does Stryker have any subsidiaries?: The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
When was Stryker founded?: Stryker was founded in 1941.
How can I contact Stryker?: Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The official website for the company is www.strykercorp.com. The medical technology company can be reached via phone at (269) 385-2600, via email at katherine.owen@stryker.com, or via fax at 269-385-1062.

This page (NYSE:SYK) was last updated on 8/15/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Stryker - SYK Stock Forecast, Price & News

Stryker MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Stryker (NYSE:SYK) Stock

Analyst Upgrades and Downgrades

Stryker Stock Up 0.1 %

Stryker Announces Dividend

SYK Stock News Headlines

SYK Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

SYK Stock - Frequently Asked Questions

Should I buy or sell Stryker stock right now?

What is Stryker's stock price forecast for 2022?

How have SYK shares performed in 2022?

When is Stryker's next earnings date?

How were Stryker's earnings last quarter?

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Is Stryker a good dividend stock?

What guidance has Stryker issued on next quarter's earnings?

What is Kevin A. Lobo's approval rating as Stryker's CEO?

What other stocks do shareholders of Stryker own?

What is Stryker's stock symbol?

Who are Stryker's major shareholders?

How do I buy shares of Stryker?

What is Stryker's stock price today?

How much money does Stryker make?

How many employees does Stryker have?

Does Stryker have any subsidiaries?

When was Stryker founded?

How can I contact Stryker?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™